This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use

News

Bionow members are welcome to submit PR items to this newsroom for all to see. An animated website user guide is available here which demonstrates how members can add news directly to the website after logging in. 

Whether currently a member or not, to keep in touch with all relevant news and information make sure you are registered to receive our newsletter.

David Cameron 2 

Former PM David Cameron joins Northern Businesses Showcasing UK Life Science

21 June 2017

The world’s largest biotech gathering taking place in San Diego this week, the BIO Convention, has seen the North of England showcase its offer to more than 60 countries - and former Prime Minister David Cameron talk down fears over what Brexit will mean for the sector.

> Read More

 

Manchester start-up creates world’s most powerful optical microscope

20 June 2017

LIG Nanowise, based at Manchester Science Park, specialise in microscope technology aimed at the industrial, medical and research and development sectors.

> Read More

 

MRC Technology Becomes LifeArc with £500M Investment and Seed Fund Plans

20 June 2017

The U.K.’s MRC Technology medical research charity has changed its name to LifeArc and unveiled plans to set up two seed and research funding initiatives as part of a projected £500 million, five-year investment in innovative research in areas including antimicrobials, neuroscience, personalized oncology, and respiratory medicine.

> Read More

Shield 

Shield Therapeutics Completes £12M Fundraising

20 June 2017

Newcastle-based Shield Therapeutics has completed its £12m fundraising.

> Read More

 

Cytox raises £2.6m led by Catapult Ventures to launch predictive test for Alzheimer’s Disease

14 June 2017

Cytox, a leader in genetic testing for Alzheimer’s Disease, announces that it has raised £2.6m to fund the commercial launch and international roll out of its novel service, in a funding round led by the GM&C Life Sciences Fund, managed by Catapult Ventures.

> Read More